The coumarin-3-cinnamoyl derivatives 2a-d were prepared via ClaisenSchmidt condensation of 3-acetylcoumarin 1 with different aromatic aldehydes. 
Introduction
Coumarins have been found to be physiologically active in animals as well as in man [I] . Many biological properties for coumarins have been reported such as dermal photosensitizing activity [2-41, antimicrobial [5-71, diuretic [8,9] , molluscicidal and anthelminitic [I 0,l I] , vasodilatory [ I 2,131, estrogenic [14] , anticoagulant [ I 5-181 and antitumor [ I 9-22] activities.
It has been reported that substituted pyridine derivatives showed antimicrobial [23, 24] , antitumor [25, 26] , analgesic and anticonvulsant [27] activities. Also pyrimidine derivatives showed anticancer [28, 29] , antimicrobial [30, 31] , antiviral [32] , cytotoxic [33] , antitumor [34] and antidepressant [35] activities.
Based on the previous findings, it is of interest to synthesize some new coumarin-3-derivatives starting with 3-acetylcoumarin and incorporating to biologically active moieties such as pyrimidine, cyanopyridine and cyanopyridone.
Experimental
All melting points are uncorrected and were taken on Electro-thermal IA 9000 series digital melting point apparatus. Analytical data were obtained from the microanalytical unit, National Research Centre, Cairo, Egypt. The I R spectra (KBr) were recorded on a Pye Unicam SP-1000 spectrophotometer. The 'H-NMR spectra (6, ppm) were recorded at 270 MHz on Varian EM-360 Spectrometer using TMS as an internal standard. The Central Services Laboratory, National Research Centre.
The mass spectra were performed using VG 2AB-3F spectrometer (70eV). All reactions were followed by TLC (silica gel, aluminum sheets 60 F254, Merck). The physical and analytical data of the synthesized compounds are given in Table 1 .
Synthesis of 3-cinnamoyl-coumarin derivatives 2a-e:
General procedure A mixture of 3-acetylcoumarin 1 (2 mmol), the appropriate aldehyde (2 mmol), namely, benzaldehyde, p-fluorobenzldehyde, p-nitrobenzaldehyde, salicylaldehyde, 5-methyl furfural, and few drops triethylamine in 30 ml absolute ethanol was refluxed for 4-6 hr. The reaction mixture was cooled and the separated solid was filtered off, air-dried and crystallized from the proper solvent to afford compounds 2a-e [36] .
Formation of 3-(2-amin0-4-aryl-3,4-dihydropyrimidine-6-l) benzopyran-2-one 3a, b:
General procedure
To a solution of compounds 2b,e (2 mmol), sodium hydroxide (0.2g in 1 ml water) in ethanol (30 ml), guanidine hydrochloride (0.2g, 2 mmol) was added. The reaction mixture was refluxed for 5-7 hr, allowed to cool, then poured onto cold water, the solid formed was collected by filtration and crystallized from the proper solvent to give compounds 3a,b, respectively. Synthesis of 3-(4-aryl-l,2,3,4-tetrahydropyrimidine-2-thioxo-6-yl)benzopyran-2-one 4a,b:
To a mixture of 2b,e (2 mmol), sodium hydroxide (0.29 in I ml water) in ethanol (30 ml), thiourea (0.15g, 2 mmol) was added. The reaction mixture was heated under reflux for 3-5 hr, allowed to cool. The solid formed was filtered off and crystallized from the proper solvent to give the corresponding thioxopyrimidine derivatives 4a,b.
Preparation of compounds 5a,b and 6a,b:
General procedure A mixture of compounds 4a,b (2 mmol), chloroacetic acid or bromopropionic acid (2 mmol) in a mixture of glacial acetic acid (30 ml) and acetic anhydride (10 ml) in the presence of anhydrous sodium acetate (39) was refluxed for 6-7 hr. The reaction mixture was cooled and poured onto cold water with stirring, the solid formed was filtered off and crystallized from the proper solvent to give the corresponding 5a,b and 6a,b, respectively.
Preparation of 3-12-aryl-methylene-5 '-aryl-2,3-dihydro-5H-thiazolo[3,2-a] pyrimidine-3-one-7-flbenzopyran-2-one 7a, b:
A mixture of compound 4a,b (2 mmol), chloroacetic acid (0.19g, 2 mmol), sodium acetate anhydrous (3g) in glacial acetic acid (30 ml), acetic anhydride (10 ml) and the appropriate aldehydes (2 mmol) was refluxed for 5-6 hr. The reaction mixture was cooled and poured onto ice-water, the obtained solid was collected by filtration and crystallized from the proper solvent to give compounds 7a,b.
Method 6:
A mixture of compound 5a,b (2 mmol), the appropriate aldehydes (2 mmol), acetic acid (30 ml) and acetic acid anhydride (10 ml) was refluxed for 2-3 hr., allowed to cool, then poured onto water the solid formed was collected by filtration and crystallized from the proper solvent to yield the title compounds 7a,b.
The obtained products from method B were identified by m.p., mixed m. p.'s and TLC by comparison with authentic samples, but method (A) gives better yield than method (B).
Preparation of cyanoaminopyridine 8a-e and cyanopyridone 9a-e derivatives:
Method A:
A mixture of Za,e (2 mmol), malononitrile or ethyl cyanoacetate (2 mmol) and ammonium acetate (0.39, 4 mmol) in absolute ethanol (30 ml) was refluxed for 3-5 hr. After cooling, the formed product was collected by filtration, washed with ethanol, dried and crystallized from the proper solvent to give the corresponding cyanoaminopyridines 8a-e and cyanopyridones 9a-e, respectively.
Method B:
A mixture of 3-acetylcoumarin 1 (0.389, 2 mmol), I ,I-dicyano-2-arylethylene or I-cyano-I-ethyl ester-2-arylethylene (2 mmol) and ammonium acetate (0.30g, 4 mmol) in absolute ethanol (30 ml) was refluxed for 5-7 hr. The reaction mixture was concentrated and left to cool. The formed solid was filtered off and crystallized from the proper solvent to give the corresponding 8a-e and gage, respectively.
Method C:
A mixture of 3-acetylcoumarin 1 (0.38g, 2 mmol), the appropriate aldehydes A 100% response is expected fresh tryptamine HCI solution should be prepared hourly as needed [37, 38] . 
Evaluation:
The normalized percent potentiation is calculated as follows:
% animals potent in drug group-% animals potent in vehicle 100 X I -% animals potent in vehicle group A dose-response was obtained in the same manner at the peak time of drug effect expect that a group size of 10 animals is used and four different doses are tested in addition to the vehicle and the TranylcypromineB groups.
All the tested compounds showed potent antidepressant activities via MA01 mechanism than TranylcypromineB. Compounds 6a, 7b and 9b showed 12.8, 12.1 5, 12.06 more activities than that of TranylcypromineB respectively, these compounds exhibit good therapeutic windows & high safety margins.
Compounds 3b, 5a, 5b and lob showed also potent MA01 activities but less than that previously mentioned, their relative potencies of 10.14, 10.1 1 , 10.51 and 11.66 of that of the standard drug. Compounds 2b, 3a, 4a, 8c, 8b, 8e, 9d and 10c showed from 7-8 folds more activities than that of standard, while compounds 2d, 2e, 4b, 6b, 8d, 9c and 11 showed from 4-6 folds of the activities of TranylcypromineB. The rest of compounds showed less than 4 folds of the activities of reference drug. Also, reaction of 2b,e with thiourea in ethanolic sodium hydroxide yielded 3-(4-aryl-I ,2,3,4-tetrahydropyrimidine-2-thioxo-6-yl)benzopyran-2-one 4a,b (Scheme 1).
The IR spectra of compounds 4a,b showed two absorption bands at 3445-3430 (NH) and 1 195, 1 190 characteristic for the C-0-C system and at 1275, 1280 (C=S).
The 'H-NMR spectrum of compound 4b showed signals at 5.10 (1 H, dd, Ha pyrimidine), 9.50 (2H, s, 2NH which exchangeable with D20), 7.25-7.75 (5H, m, 4 Ar-H and Hb pyrimidine) besides the other characteristic signals for the compound. The mass spectrum of compound 4b exhibited peaks at mlz, 338 (M', 2.38%), 312 (50.7%), 237 (64.3%) and base peak at 267 (100%).
The reaction of a,&unsaturated ketones 2 with thiourea can proceed by addition on carbonyl group of 2 followed by cyclization and dehydrogenation to yield the final products 4. The force for such elimination reactions is the resonance stabilization energy in 4. We were not able to isolate any intermediate [23, 39] . Several publications [42-441 reported that the reaction of 1,2-diamines with a,P-unsaturated ketones gave products depend on the experimental conditions. In the present work 3-styryl coumarin 2a,b,e reacted with 1,2-phenylene diamine under different conditions. The uncatalyzed reaction in refluxing butanol afforded the substituted diazepino derivatives 10a-c (Scheme 3).
The IR spectra of 10a-c showed bands at 3385-3340 (NH) and at 1612-1608 (C=N), while bands corresponding to (C=O) of a,P-unsaturated ketones and NH2 of the diamine were not observed. 
Scheme (2)
The Mass spectrum of compound 10c exhibited peaks at mlz 370 (Mt, 63%), 280 (98.17%), 265 (1 00%, base peak), 237 (1 5.55%), 209 (21.67%).
Formation of 10 was believed to take place with the addition of the diamine ethylenic double bond of 2, followed by interamolecular condensation of the amino group with the carbonyl function, affording 10 as final products (Scheme 3).
On the other hand, compounds 2a,b,e were fused with o-phenylenediamine at 200-220°C to afford benzimidazole derivative 11 as the main product along with the benzimidazole derivatives 12a-c (Scheme 3). The IR spectrum of 11 showed peak at 3345 (NH). The 'H-NMR spectrum of 11 showed signals at 10. 
Scheme (3)
Formation of benzimidazoles 11 and 12 are presumed to proceed through the intermediate formation of the corresponding diazepine derivatives 10, followed its cleavage to give mixture of 11 and 12 depending on the mode of cleavage as follows:
